Rayos Interactions
There are 627 drugs known to interact with Rayos (prednisone), along with 22 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 79 are major, 505 are moderate, and 43 are minor.
- View all 627 medications that may interact with Rayos
- View Rayos alcohol/food interactions (2)
- View Rayos disease interactions (22)
Most frequently checked interactions
View interaction reports for Rayos (prednisone) and the medicines listed below.
- amlodipine
- amlodipine
- cyclobenzaprine
- cyclobenzaprine
- Cymbalta (duloxetine)
- Cymbalta (duloxetine)
- doxycycline
- doxycycline
- folic acid
- folic acid
- gabapentin
- gabapentin
- hydroxychloroquine
- hydroxychloroquine
- Lyrica (pregabalin)
- Lyrica (pregabalin)
- methotrexate
- methotrexate
- omeprazole
- omeprazole
- pantoprazole
- pantoprazole
- Plaquenil (hydroxychloroquine)
- Plaquenil (hydroxychloroquine)
- tramadol
- tramadol
- Vitamin B12 (cyanocobalamin)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Vitamin D3 (cholecalciferol)
Rayos alcohol/food interactions
There are 2 alcohol/food interactions with Rayos (prednisone).
Rayos disease interactions
There are 22 disease interactions with Rayos (prednisone) which include:
- infections
- (+) tuberculin test
- cirrhosis
- depression/psychoses
- diabetes
- electrolyte imbalance
- fluid retention
- GI perforation
- hyperadrenocorticalism
- hyperlipidemia
- hypothyroidism
- liver disease
- MI
- myasthenia gravis
- myopathy
- ocular herpes simplex
- ocular toxicities
- osteoporosis
- PUD
- scleroderma
- strongyloidiasis
- thromboembolism
Report options
More about Rayos (prednisone)
- Rayos consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: glucocorticoids
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Otezla
Otezla (apremilast) is used to treat plaque psoriasis, psoriatic arthritis, and oral ulcers ...
Skyrizi
Skyrizi (risankizumab) is used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis ...
Benlysta
Benlysta infusion is used to treat active systemic lupus erythematosus (SLE) and active lupus ...
Breztri Aerosphere
Breztri (budesonide/glycopyrrolate/formoterol fumarate) is a combination inhaler used for the ...
Stelara
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Xolair
Xolair injection (omalizumab) is used to help improve allergic asthma, nasal polyps, and chronic ...
Triamcinolone
Triamcinolone is used to treat allergies, skin conditions, ulcerative colitis, and arthritis. Learn ...
Celecoxib
Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain or inflammation ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
